Safety and Feasibility of Early Discharge Using the Portico Self-Expanding Prosthesis for Transfemoral Transcatheter Aortic Valve Replacement: The SAFE TAVR Study
Principal Investigator
David WoodOverview
Body Locations and Systems
HeartDiagnosis and Therapy
Heart SurgeryClinicalTrials.gov#
NCT03600935Status
RecruitingStudy Start/End
Oct 22, 2018 to Dec 31, 2020Locations
Vancouver General HospitalName/Title
Brady Robinson, Research CoordinatorPhone
604-875-5106Email Address
brady.robinson@vch.caPurpose of Study
The purpose of this study is to determine the efficacy, safety and feasibility of next day discharge in patients undergoing self-expandable transfemoral TAVR utilizing the Vancouver 3M Clinical Pathway.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.